Skip to main content
Patient safety

Guidance and regulation

120 results sorted by Most viewed
  • Guidance on out of specification investigations, including definitions and laboratory analysis and phase I,II and III investigations.

  • How to register on the MHRA portal and use it to apply for and update marketing authorisations and make other applications.

  • These documents remind health services of their duties to safeguard adults.

  • How the death certification process in England and Wales will change from April 2024, including the introduction of medical examiners.

  • Guidance to help applicants and licence holders get and maintain a wholesale dealer licence (WDA(H)) or broker registration – MHRA guidance note 6.

  • Sets out government policy on safeguarding vulnerable adults, including a statement of principles for use by local authorities.

  • A list of herbal medicines currently holding a traditional herbal registration (THR) granted by the Medicines and Healthcare products Regulatory Agency (MHRA).

  • How to join the phase I accreditation scheme.

  • Licences and regulations for organisations that handle human blood or blood products and reporting adverse incidents with blood through SABRE.

  • Current listing of UK brokers authorised to broker human medicines, including company name, registration and address.

  • The Department of Health and Social Care will lead a review into the duty of candour for health and social care providers in England.

  • Guidance explaining the main features of the Medical Devices Regulations 2002 (SI 2002 No 618, as amended) in relation to in vitro diagnostic medical devices

  • Guidance for healthcare and social services organisations on managing medical devices in practice.

  • How to comply with the requirements on promoting medicines to the public and to prescribers and suppliers of medicines.

  • Sets out the progress made in applying the lessons learned from the failings at Mid Staffordshire NHS Foundation Trust.

  • An overview of the legal requirements for children’s medicines that Marketing Authorisation Holders (MAHs) need to abide by.

  • Register as a manufacturer, importer or distributor of active substances.

  • Cancel a marketing authorisation, traditional herbal registration or parallel import product licence or withdraw a pending submission.

  • Relevant safety information for users of magnetic resonance imaging (MRI) equipment in clinical use.

  • Reporting, investigating and recalling suspected defective medicinal products to the Defective Medicines Report Centre (DMRC).